All COVID-19 n=168 | Healthcare worker | P value | ||
Yes n=36 | No n=132 | |||
Duration of follow-up | ||||
Days to visit 3 or death, (median IQR) | 420 (370, 446) | 425 (368, 555) | 420 (380, 442) | 0.326 |
Outcomes, n (%) | ||||
Death or hospitalisation (any cause) | 23 (14%) | 1 (3%) | 22 (17%) | 0.038 |
Death (any cause) | 2 (1%) | 0 (0%) | 2 (2%) | 0.457 |
Cardiovascular death | 1 (1%) | 0 (0%) | 1 (1%) | 0.597 |
Renal death | 0 (0%) | 0 (0%) | 0 (0%) | – |
Respiratory death | 0 (0%) | 0 (0%) | 0 (0%) | – |
Hospitalisation (any cause) | 23 (14%) | 1 (3%) | 22 (17%) | 0.038 |
Secondary care (outpatients) | ||||
Any outpatient care | 113 (67%) | 27 (75%) | 86 (65%) | 0.192 |
Acute COVID-19 (<28 days) | 15 (9%) | 4 (11%) | 11 (8%) | 0.614 |
Ongoing COVID-19 (28–84 days) | 22 (13%) | 4 (11%) | 18 (14%) | 0.702 |
Long COVID-19 (>84 days) | 65 (39%) | 15 (42%) | 50 (38%) | 0.934 |
For clinical outcomes, data are the number and percentage of participants with at least one event during follow-up. P values are from log-rank tests of the time to the first event. A p value of less than 0.05 was considered significant.